In August of the Golden Autumn, Lingrui Pharmaceutical was nominated the titles of "2020’s Healthy Chinese Brand"，"Top 100 in the Chinese Pharmaceutical Industry" and shortlisted the “3rd China OTC Brand Promotion Month”
Between August 13-17th 2020, the 2020 Cypress Conference was held in Boao, Hainan Province, China. The year’s theme being "Beginning a New Era of Life Cycle Health Management", Chairmen and General Managers of Lingrui Pharmaceutical Xiong Wei and Wu Huibin as well as others were invited to attend.
On the evening of August 14th, the Xipu Gold Award Ceremony was grandly held, and the annual health industry award "2020 Healthy Chinese Brand List" was announced. With its outstanding market performance and good public reputation, Lingrui Pharmaceutical was once again shortlisted for topical analgesics ranking, and won the Xipu Gold Award.
Meridian Obstruction Removing and Pain Relieving Plaster Patch is not only an exclusive product of Lingrui Pharmaceutical, but also a nationally protected product of traditional Chinese medicine. It has been repeatedly rated as the "Most Popular Rheumatology Orthopedic Medicine" and one of the "Top Ten Brands of Orthopedic Traumatology Chinese Patent Medicine" by industry experts. Appearing on the “Healthy China Brand List” is the topical medicine brand that has won the most awards; Lingrui Pediatric Fever Relieving Patch has made an appearance on the cutting-edge “Healthy China Brand List” three consecutive times, and is the only antipyretic patch brand to do so.
On the evening of August 15th, Lingrui Pharmaceutical was awarded the honorable title of "Responsibility in Fighting the Epidemic with Great Love" by the Xipu Association. Since the beginning of the year, in the face of this sudden COVID epidemic, Lingrui Pharmaceutical has been resolved in demonstrating corporate social responsibility, in line with their philosophy of “establishing a business with integrity and benefiting mankind”. Responding quickly and actively, Lingrui has donated more than 10 million yuan to date in contribution to the fight against the epidemic.
external medicinal products such as Meridian Obstruction Removing and Pain-Relieving Plaster Patch, Musk Bone-strengthening and Pain-relieving Plaster Patch and Pain-relieving Tincture, etc. attracted a large number of guests to come and experience relaxing massages provided by the Lingrui staff. The advantages of combined medication with periodic administration in the treatment of nerve root cervical spondylosis, particularly with Lingrui’s "meridian obstruction removing” as well as “invigorate blood" products, were well-noted by the guests.
During the meeting, Xiong Wei and Wu Huibin conversed extensively with senior managers of many large pharmaceutical chains, including Gaoji , Yixintang, Quanyi, and Jiuzhou, on strategic co-operation between the parties.
On August 25, 2020, the 2020 China Pharmaceutical Industry Top 100 Annual Meeting was held in Kunming, Yunnan. The “2019 China Pharmaceutical Industry Top 100 Series List” was announced on the spot. Lingrui Pharmaceutical ranked 31st out of 100 due to its comprehensive strength, jumping up 9 places from the previous year and demonstrating the continued dedication to excellence of the company. This selection focuses on both the innovative prowess and professional leadership in industrial enterprises, where innovation has also been the main theme that development has been centered around at Lingrui Pharmaceutical.
On August 29, 2020, the 3rd China OTC Brand Promotion Month was held in Hangzhou, China. Lingrui’s "Pain-relieving Tincture" made an appearance as a promotional brand of the event.
